PARACETAMOL is a brand name for Acetaminophen (also known as Paracetamol). The medicine, its uses, side effects and dosage are the same regardless of brand.
Used for: Paracetamol is a mild analgesic and antipyretic, and is recommended for the treatment of most painful and febrile conditions, for example, headache, including migraine, toothache, neuralgia, colds and influenza, sore throat, backache, rheumatic pain and dysmenorrhoea.
Verbatim from this product's MHRA label. Tap a section to expand.
Posology Adults, Elderly and Children over 16 years:
Take one or two capsules up to 4 times a day. Maximum dose of 8 capsules in 24 hours.
Children aged 10 to 15 years:
Take one capsule up to 4 times a day. 'Every 4-6 hours when necessary’. Maximum dose of 4 capsules in 24 hours. The dose should not be repeated more than four times in 24 hours. The dosage should not be continued for more than 3 days without consulting a doctor.
Method of administration For oral administration
The information below lists reported adverse reactions, ranked using the following frequency classification: Very common (≥ 1/10); common (≥ 1/100 to <1/10); uncommon (≥ 1/1,000 to <1/100); rare (≥ 1/10,000 to <1/1,000); very rare (<1/10,000); not known (cannot be estimated from the available data).
Immune system disorders Hypersensitivity including skin rash may occur. Not known: anaphylactic shock, angioedema. Blood and lymphatic system disorders Not known: blood dyscrasias including thrombocytopenia and agranulocytosis. Skin and subcutaneous disorders Very rare cases of serious skin reactions such as Toxic Epidermal Necrolysis (TEN), Stevens-Johnson syndrome (SJS), acute generalized exanthematous pustulosis, fixed drug eruption have been reported.
4). Pyroglutamic acidosis may occur as a consequence of low glutathione levels in these patients. Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important.
It allows continued monitoring of the benefit/risk balance of the medicinal product. uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
Paediatric population Not recommended for children under 10 years of age. Care is advised in the administration of paracetamol to patients with severe renal or severe hepatic impairment. The hazard of' overdose is greater in those with non-cirrhotic alcoholic liver disease.
Do not exceed the recommended dose. Do not take paracetamol for more than 3 days without consulting a doctor. Do not take with any other paracetamol-containing products. If symptoms persist, consult your doctor. Keep out of the reach of children.
g. chronic alcoholism) who were treated with paracetamol at therapeutic dose for a prolonged period or a combination of paracetamol and flucloxacillin. If HAGMA due to pyroglutamic acidosis is suspected, prompt discontinuation of paracetamol and close monitoring is recommended.
The measurement of urinary 5-oxoproline may be useful to identify pyroglutamic acidosis as underlying cause of HAGMA in patients with multiple risk factors. Immediate medical advice should be sought in the event of an overdose even if you feel well, because of risk of delayed, serious liver damage.
1
Not medical advice. Always read the patient information leaflet and follow your prescriber or pharmacist.
Other brands of Acetaminophen in United Kingdom.
Know a brand we are missing in United Kingdom? Suggest a brand →
Brand names are compiled from public regulatory records for active-ingredient mapping only. Drugvu is not affiliated with any manufacturer. This is not medical advice.